|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001758,
umls-concept:C0007226,
umls-concept:C0011786,
umls-concept:C0013790,
umls-concept:C0028754,
umls-concept:C0043210,
umls-concept:C0392747,
umls-concept:C0442828,
umls-concept:C0444706,
umls-concept:C0724441,
umls-concept:C0817096
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2000-1-24
|
|
pubmed:abstractText |
An anorectic drug, dexfenfluramine (dF) is commonly used in obesity treatment. The aim of our study was to investigate if dexfenfluramine used alone or together with alpha 2-adrenolitic yohimbine (Y), can change cardiovascular state in obese women.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0006-6648
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
138
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
359-63
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10597657-Adrenergic alpha-Antagonists,
pubmed-meshheading:10597657-Adult,
pubmed-meshheading:10597657-Appetite Depressants,
pubmed-meshheading:10597657-Dexfenfluramine,
pubmed-meshheading:10597657-Electric Impedance,
pubmed-meshheading:10597657-Exercise Test,
pubmed-meshheading:10597657-Female,
pubmed-meshheading:10597657-Hemodynamics,
pubmed-meshheading:10597657-Humans,
pubmed-meshheading:10597657-Obesity,
pubmed-meshheading:10597657-Yohimbine
|
|
pubmed:articleTitle |
Cardiovascular changes after treatment with dexfenfluramine and yohimbine in obese women measured by thoracic electrical bioimpedance.
|
|
pubmed:affiliation |
Department of Gastroenterology, Silesian Medical Academy, Katowice, Poland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
